Understanding the 'Razor Blade' COVID-19 Variant and Its Symptoms

A new COVID-19 variant known as NB.1.8.1, or "Nimbus," has been linked to a recent increase in cases around the world, particularly in regions such as the eastern Mediterranean, Southeast Asia, and the western Pacific. This variant has gained attention because it appears to cause notably painful and sore throats, earning it the nickname "razor blade" sore throat among health professionals.

Medical experts in the UK, India, and other countries have observed that individuals infected with this variant often experience severe sore throats. Besides the distinct sore throat, common COVID-19 symptoms like fever, chills, cough, shortness of breath, and loss of taste or smell continue to be indicators of infection.

The World Health Organization (WHO) reports that the rise in cases containing this variant surfaced late last month. It constituted approximately 11% of sequenced samples globally in mid-May. Detection efforts at U.S. airports have identified travelers infected with the Nimbus variant from affected regions, mainly arriving in states such as California, Washington, Virginia, and New York.

Concerning severity, current data suggest that this variant does not lead to more severe illness than other COVID-19 strains. Hospitalization rates and case numbers have increased in some Western Pacific countries, but there is no evidence yet indicating increased virulence.

Vaccination remains effective against the Nimbus variant. The WHO classifies it as a "variant under monitoring" and maintains that the global public health risk remains low. Current COVID-19 vaccines are expected to continue providing protection against severe outcomes.

Recently, health authorities have updated recommendations, with some officials, like Robert F. Kennedy Jr., suggesting that COVID-19 shots may no longer be necessary for healthy children and pregnant women, which has sparked debate among health experts.

While vigilance is advised, experts agree that the Nimbus variant does not appear to pose a greater threat than previous strains. Nonetheless, monitoring and vaccination are key strategies in controlling its spread.

Source: https://medicalxpress.com/news/2025-06-covid-variant-razor-blade-sore.html